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Cleaning up translation failures: how Ribosome-associated Quality Control maintains 
cellular proteostasis 
Kelsey Hickey 
 
ABSTRACT 
Ribosome-associated Quality Control (RQC) pathways protect cells from toxicity caused 
by incomplete protein products resulting from translation of damaged or problematic mRNAs.  
One component of the RQC pathway, Ltn1p, is an E3 ubiquitin ligase that targets partially 
synthesized polypeptides for ubiquitin-proteasome mediated degradation. A second core RQC 
component, Rqc2p, not only nucleates the complex formation but also modifies the nascent 
polypeptide by adding a carboxyl-terminal alanine and threonine (CAT) tail through a 
noncanonical elongation reaction. We found that Ltn1p can efficiently access only nascent-chain 
lysines immediately proximal to the ribosome exit tunnel. For substrates without Ltn1p-
accessible lysines, CAT-tailing by Rqc2p expanded the range of RQC-degradable substrates by 
exposing lysines sequestered in the ribosome exit tunnel.  
Although the core RQC factors are conserved from yeast to human, much less is known 
about the mammalian counterparts. Interestingly, the phenotypes observed with loss of RQC in 
mammals are more severe and include cytotoxicity at a cellular level, and neurodegeneration at 
an organismal level. Due to the increased requirement for RQC in mammals, we used CRISPR-
Cas9-based screening to search for additional RQC strategies in mammals. We found that failed 
translation leads to specific inhibition of translation initiation on that message. This negative 
feedback loop is mediated by two translation inhibitors, GIGYF2 and 4EHP. Both model 
substrates and growth-based assays established that inhibition of additional rounds of translation 
	 vi 
acts in concert with known RQC pathways to prevent buildup of toxic proteins. Inability to block 
translation of faulty mRNAs, and subsequent accumulation of partially synthesized polypeptides, 
could explain the neurodevelopmental and neuropsychiatric disorders observed in mice and 
humans with compromised GIGYF2 function.  
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1. INTRODUCTION 
Translation is an enormous amplification step in which each messenger RNA (mRNA) is 
turned into hundreds of proteins. Defective mRNAs lacking a stop codon due to premature 
polyadenylation or mRNAs harboring damage, non-optimal codons or RNA structure can cause 
ribosomes to stop translating before they reach a stop codon (Doma and Parker, 2006; Klauer 
and van Hoof, 2012; Letzring et al., 2013). Such stalled ribosomes pose numerous threats to the 
cells as they decrease protein output from an mRNA, block translation by trailing ribosomes, and 
carry incomplete polypeptide that can aggregate or exhibit dysregulated activity (Choe et al., 
2016; Chu et al., 2009; Yonashiro et al., 2016a). Therefore, if ribosome stalling is not detected 
and resolved, it can jeopardize cell and organismal viability. 
To counter the threat posed by stalled ribosomes, cells possess multiple surveillance 
mechanisms, collectively referred to here as Ribosome-associated Quality Control (RQC) 
pathways. Recent studies have shown that one of the earliest events that can initiate RQC is the 
collision between the stalled ribosome and a trailing one (Juszkiewicz and Hegde, 2017; 
Juszkiewicz et al., 2018; Simms et al., 2017a; Sundaramoorthy et al., 2017). One mechanism of 
detection of such collided disomes is mediated by an E3 ubiquitin ligase Hel2p (ZNF598 in 
human) (Brandman et al., 2012; Garzia et al., 2017; Juszkiewicz et al., 2018; Letzring et al., 
2013; Matsuo et al., 2017; Saito et al., 2015; Shao et al., 2015; Sundaramoorthy et al., 2017).  
After detection, the stalled ribosome is dissociated by the combined action of Dom34p/ Hbs1p 
(Izawa et al., 2012) and the RQC-Trigger complex (Hashimoto et al., 2020; Matsuo et al., 2017). 
The 60S ribosome, which still carries the stalled nascent polypeptide, recruits the core RQC 
complex components, allowing the nascent polypeptide to be ubiquitinated and extracted from 
		 2 
the exit tunnel for proteasomal degradation (Bengtson and Joazeiro, 2010; Brandman et al., 
2012; Kostova et al., 2017; Osuna et al., 2017).  
The RQC complex in Saccharomyces cerevisiae comprises Rqc1p, Rqc2p, the E3 
ubiquitin ligase Ltn1p, and Cdc48p. Rqc2p acts to both recruit Ltn1p and to facilitate tagging of 
partially synthesized polypeptides with a Carboxy-terminal Alanine and Threonine (CAT) tail in 
a non-canonical elongation reaction (CAT-tailing) (Shen et al., 2015). Previous studies 
established that CAT-tails facilitate protein aggregation when RQC-mediated degradation is 
compromised, leading to chaperone sequestration and proteotoxic stress (Choe et al., 2016; 
Defenouillère et al., 2016; Yonashiro et al., 2016b). However, an Rqc2p mutant defective in 
CAT-tailing (Rqc2pmut) fully supports Ltn1p-dependent degradation of the limited number of 
stalling substrates studied so far (Choe et al., 2016; Defenouillère et al., 2016; Shen et al., 2015; 
Yonashiro et al., 2016b). We found that the biological role of CAT-tailing in the context of a 
functional RQC is to expose hidden lysines from the exit tunnel, thus expanding the number of 
substrates which can be ubiquitinated by Ltn1p and subsequently degradation.  
These quality control pathways have been discovered and extensively studied in yeast. 
However, far less is known about their conserved counterparts in mammals. In contrast to yeast, 
where loss of core RQC factors is well tolerated under standard growth conditions, mutations in 
the mammalian factors affect cell growth and have been associated with complex disease. For 
example, partial loss-of-function mutations in LTN1, the ubiquitin ligase facilitating the 
degradation of the stalled nascent polypeptide, cause neurodegeneration in mice (Bengtson and 
Joazeiro, 2010; Chu et al., 2009). Together, these observations further emphasize the importance 
of RQC for maintaining protein homeostasis in higher eukaryotes (Brandman et al., 2012; 
Defenouillère et al., 2013; Shao and Hegde, 2014; Shao et al., 2013; Verma et al., 2013). Given 
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the toxicity of partially synthesized proteins, it is possible that multiple layers of regulation exist 
to prevent, detect, and cope with ribosome stalling. However, our understanding of how the RQC 
cooperates with other pathways governing protein homeostasis is incomplete. Here we use 
reporter-based and growth-based genome-wide CRISPRi screens (Gilbert et al., 2014; Qi et al., 
2013) to systematically characterize the mammalian RQC pathway. We identify a new branch of 
the RQC that involves two factors, GIGYF2 and 4EHP, that block ribosome initiations on 
problematic mRNAs.  
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2. RESULTS 
2.1. RQC substrates require lysine residues to be degraded 
In eukaryotic cells, when translation fails (e.g., due to a faulty mRNA or ribosome 
stalling) the incomplete nascent chain is targeted for proteasomal degradation (Ito-Harashima et 
al., 2007) by a conserved ribosome-associated quality control pathway (Brandman and Hegde, 
2016). This process involves disassociation of the mRNA and 40S subunit followed by 
recruitment of the Ribosome-associated Quality Control (RQC) complex (Brandman et al., 2012; 
Defenouillère et al., 2013; Shao and Hegde, 2014; Shao et al., 2013; Verma et al., 2013) to the 
60S subunit-nascent chain complex (Fig. 1). The RQC complex in Saccharomyces cerevisiae 
comprises Rqc1p, Rqc2p, the E3 ubiquitin ligase Ltn1p, and Cdc48p. Rqc2p acts to both recruit 
Ltn1p and to facilitate tagging of partially synthesized polypeptides with a Carboxy-terminal 
Alanine and Threonine (CAT) tail in a non-canonical elongation reaction (CAT-tailing) (Fig. 1) 
(Shen et al., 2015). Previous studies established that CAT-tails facilitate protein aggregation 
when RQC-mediated degradation is compromised, leading to chaperone sequestration and 
proteotoxic stress (Choe et al., 2016; Defenouillère et al., 2016; Yonashiro et al., 2016b). 
However, an Rqc2p mutant defective in CAT-tailing (Rqc2pmut) fully supports Ltn1p-dependent 
degradation of the limited number of stalling substrates studied so far (Choe et al., 2016; 
Defenouillère et al., 2016; Shen et al., 2015; Yonashiro et al., 2016b). Thus, the biological role of 
CAT-tailing in the context of a functional RQC remains undefined. 
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Figure 1. RQC pathway in yeast. Model for RQC-mediated degradation of nascent 
polypeptides. 
 
 
To investigate the role of CAT-tailing in nascent polypeptide degradation, we designed 
two stalling constructs (GFP20Lys and GFPLys-free) that differed in whether or not they encoded 
lysines, the canonical ubiquitin acceptor (Fig. 2B, C). Both constructs contained a poly-arginine 
track (R12) that efficiently blocked translation (Dimitrova et al., 2009; Letzring et al., 2010). The 
resulting GFP20Lys nascent polypeptide was degraded in an RQC-dependent manner (Fig. 2B). In 
ltn1Δ cells, we detected higher molecular weight CAT-tailed species, which collapsed into a 
discrete band upon removal of C-terminal extensions by TEV protease treatment (Fig. 2B, 
middle panel). Finally, consistent with previous work (Shen et al., 2015), GFP20Lys was 
efficiently degraded in the CAT-tailing deficient rqc2mut strain, confirming that CAT-tails are not 
necessary for degradation of this substrate (Fig. 2B). 
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Figure 2. Degradation of RQC substrates requires lysines. (B, C) Immunoblots (IBs) of 
stalling reporters with or without lysines in RQC deletion strains. 	
 
 
 
In contrast to GFP20Lys, GFPLys-free was heavily CAT-tailed even in wild-type (wt) cells 
(Fig. 2C), consistent with previous reports (Yonashiro et al., 2016b). However, these CAT-tails 
did not trigger degradation, since comparable amounts of GFPLys-free accumulated in wt cells and 
RQC deletions strains (Fig. 2C). This indicates that CAT-tails do not function as degrons, as 
their addition alone is not enough for RQC mediated degradation.   
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2.2. Direct Ltn1p ubiquitination mediates RQC substrate degradation  
Cryo-electron microscopy structures of Ltn1p bound to the 60S subunit have revealed 
that the RING domain of Ltn1p, which is required for ubiquitin transfer, is held in close 
proximity to the ribosome exit tunnel (Lyumkis et al., 2014; Malsburg et al., 2015). Thus, the 
position of lysines along the nascent polypeptide may determine the ability of Ltn1p to 
ubiquitinate them. To further explore this idea, we designed stalling constructs with four lysines 
in an unstructured region (3xFLAG tag) that were systematically displaced from the R12 stalling 
site by 0, 10, 20, 40, or 80 amino acids of neutral XTEN linker (Schellenberger et al., 2009) 
(XTEN0-80, respectively) (Fig. 3). For these constructs, the four lysines will be either 
sequestered in (XTEN0), emerging from (XTEN10, XTEN20), or past (XTEN40, XTEN80) the 
ribosome exit tunnel. Initially, we used the relative degradation of the constructs as a proxy for 
Ltn1p’s ability to ubiquitinate the lysines. 
 
 
 
Figure 3. Lysine positioning is critical for proteasomal degradation. Scheme of constructs 
used (left), IB of TEV-treated XTEN constructs (right). 	
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In contrast to previous RQC substrates (Shen et al., 2015), XTEN0 was efficiently 
degraded only in cells capable of CAT-tailing in an Ltn1p-dependent manner (Fig. 3). These data 
argue that CAT-tail elongation pushes sequestered lysines out of the exit tunnel making them 
available for Ltn1p-mediated ubiquitination, as hypothesized (Brandman and Hegde, 2016; 
Simms et al., 2017b). Compared to XTEN0, degradation of XTEN10 and XTEN20 became less 
dependent on CAT-tailing (Fig. 3). Critically, when the lysines were positioned past a certain 
distance (XTEN40 and XTEN80), the substrates were completely resistant to RQC-mediated 
degradation.  
To ensure that the observed degradation was mediated through the direct ubiquitination 
of nascent chains by Ltn1p, we developed an in vivo ubiquitin assay. First, GFP20Lys was 
expressed, followed by immunoprecipitation using the encoded 3xFLAG tag. Myc-tagged 
ubiquitin was co-expressed, and cells were treated with MG132 to inhibit proteasome mediated 
degradation. These constructs were analyzed for ubiquitinated species (Myc-ubiquitin) by 
western blot (Fig. 4A). We found that we could successfully detect ubiquitinated species both in 
the cell lysate, and well as specifically on GFP20Lys after immunoprecipitation. Rqc2p and Ltn1p 
were essential for this ubiquitination of GFP20Lys, but CAT-tails were not, as Rqc2pmut strain lead 
to similar ubiquitin signal on GFP20Lys (Fig. 4B). After establishing this system, we measured the 
direct ubiquitination of the XTEN constructs to ensure that observed degradation was mediated 
through Ltn1p activity.  
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Figure 4. Ubiquitin can be detected on the GFP20Lys stalling substrate. (A) pdr5Δ cells 
expressing GFP20Lys stalling reporter and copper-inducible Myc-tagged ubiquitin were treated 
with (+) or without (-) Cu2SO4. Samples from total cell lysate or denaturing immunoprecipitation 
(Flag IP) were analyzed on SDS-PAGE and IB. (B) Cells expressing Myc-tagged ubiquitin and 
GFP20Lys stalling reporter were treated with (+) or without (-) the proteasome inhibitor MG132. 
SDS-boiled lysates from wt, rqc2mut, rqc2Δ, and ltn1Δ cells were used for Flag IP. The eluate 
was analyzed by SDS-PAGE and IB. All cells had the multidrug transporter gene PDR5 deleted 
to facilitate MG132 accumulation. 
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Figure 5. Lysine positioning is critical for Ltn1p-mediated ubiquitination and proteasomal 
degradation. (C, D) Denaturing immunoprecipitation (Flag IP) of XTEN 0, 10, and 80 stalling 
constructs from cells expressing Myc-tagged ubiquitin.	
 
 
Consistent with these degradation results, we observed Ltn1p-dependent ubiquitination of 
XTEN constructs when lysines were positioned in the exit tunnel or within the Ltn1p-accessible 
region, and no ubiquitination was observed when the lysines were past the Ltn1p-accessible 
window (Fig. 5C, 6A-D). In wild-type Rqc2p cells, XTEN0 and XTEN10 were both efficiently 
ubiquitinated in an Ltn1p-dependent manner. In contrast, XTEN80 was not ubiquitinated by 
Ltn1p or degraded by RQC. (Fig. 5C, 6A-D). In addition, we observed similar levels of 
ubiquitination in cells expressing wild-type or mutant Rqc2p (Fig. 5D). Taken together, these 
data support a model in which Ltn1p can only access a limited window of amino acids on the 
nascent polypeptide and that the process of CAT-tailing enables Ltn1p to gain access to lysines 
sequestered in the exit tunnel. 
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Figure 6. TEV protease digest of ubiquitinated stalling reporters. (A-D) XTEN constructs 
were expressed in wt or ltn1Δ cells. All cells expressed Myc-tagged ubiquitin and had the 
multidrug transporter gene PDR5 deleted. Cells were treated with the proteasome inhibitor 
MG132 and SDS-boiled lysates were used for Flag IP. The bound material was treated with TEV 
protease or mock digested and then analyzed by SDS-PAGE and IB. The asterisk (*) points to a 
non-specific smear, which is likely a product of the buffer conditions used for the TEV digest. 
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To determine the number of residues that Ltn1p can reach, we generated GFPLys-free 
constructs with a 3xHA tag upstream of only two lysines positioned at different distances from 
the R12 stalling site (Fig. 7A). These constructs were degraded in a CAT-tail-dependent manner 
when the lysines were within or near the ribosome exit tunnel, but not when the lysines were 89 
amino acids away.  
 
Figure 7. Ubiquitination of stalling constructs is influenced by lysine positioning. (A) 
Schematic of the stalling constructs used for ubiquitin detection. Ribosome exit tunnel (~32 
amino acids) and Ltn1p-accessible window (~12 amino acids) are highlighted in green and 
purple respectively. (B, C) GFPLys-free with two lysines positioned at 19, 34 or 89 amino acids 
away from the 12R stalling site were expressed in wt or ltn1Δ cells harboring wild type (wt) or 
mutant (mut) Rqc2p. All cells expressed Myc-tagged ubiquitin and had the multidrug transporter 
gene PDR5 deleted. SDS-boiled lysates were used for HA immunoprecipitation (IP). The eluate 
was analyzed by SDS-PAGE and IB. 
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The discrete position of the lysines in these constructs allowed us to refine the Ltn1p 
accessible window to ~12 amino acids outside the ribosome exit tunnel. As observed with the 
FLAG-based constructs, the differences in degradation were consistent with differences in 
Ltn1p-mediated ubiquitination of the substrates (Fig. 7B, C). In line with degradation 
experiments, wild-type Rqc2p allowed Ltn1p-dependent ubiquitination of the constructs placing 
lysines 19, and 34 amino acids away from the stall, but not when lysines were 89 amino acids 
away. In the presence of CAT-tail deficient Rqc2p, only the construct with lysines 34 amino 
acids from the stall (right outside of the exit tunnel) could be ubiquitinated by Ltn1p (Fig. 7). In 
fact, only one lysine residue is required for efficient ubiquitination by Ltn1p. This similar 
construct encodes only one lysine upstream of an HA tag, that remains sequestered in the exit 
tunnel upon stalling. Although it can be ubiquitinated and degraded with wild-type Rqc2p, 
mutant Rqc2p cannot use CAT-tails to push this lysine out of the exit tunnel, therefore rendering 
it resistant to degradation (Fig. 8). Together, we determined the ubiquitin-dependent degradation 
by RQC requires at least one lysine within the narrow window of accessibility of Ltn1p.  
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Figure 8. CAT-tailing facilitates Ltn1p-mediated ubiquitination of a single lysine 
sequestered in the ribosome exit tunnel. GFPLys-free with a single lysine sequestered in the 
ribosome exit tunnel (diagram above) was expressed in wt, ltn1Δ, rqc2mut or rqc2mut/ltn1Δ cells. 
All cells expressed Myc-tagged ubiquitin and had the multidrug transporter gene PDR5 deleted. 
SDS-boiled lysates were used for HA IP. The eluate was analyzed on SDS-PAGE and IB. 
 
 
Upon cross comparison, the Ltn1p accessible window defined using four lysines of the 
3xFLAG tag (Fig. 3) was fully consistent with the refined window (Fig. 7) using only two 
lysines and an HA tag. Thus, the ability of Ltn1p to effectively access residues in a limited 
window proximal to the exit tunnel is primarily determined by the distance of the lysines from 
the C-terminus, rather than local sequences or structure.  
 
 
 
		 15 
 
2.3. CAT-tails expand the number of RQC degradable substrates       
Non-stop mRNAs are an important source of natural RQC substrates with lysines 
sequestered in the exit tunnel (Brandman and Hegde, 2016). For such messages, the ribosome 
translates the poly(A) tail, which appends AAA-encoded lysines to the C-terminus. The resulting 
lysines are likely to be sequestered in the ribosome exit tunnel, due to the short length of yeast 
poly(A) tails (median 27 nucleotides) (Koutmou et al., 2015; Subtelny et al., 2014). Therefore, 
CAT-tailing can expose lysines that result from translation through the poly(A) tract, allowing 
efficient ubiquitination and degradation of non-stop decay substrates. 
Having established lysine positioning as a critical determinant of CAT-tail-dependent 
degradation, we next computationally evaluated the frequency with which endogenous substrates 
would be expected to rely on CAT-tailing for degradation. While the sites of endogenous stalling 
remain poorly defined, a number of processes such as mRNA fragmentation, oxidative damage 
(Simms et al., 2014), or stress from translation inhibitors can cause stalling at any position along 
a message. We therefore considered the nascent chains produced if ribosomes stall with uniform 
probability at each codon along every coding sequence in the yeast genome (Engel et al., 2014), 
and we calculated the fraction of potential stalling sites for which there are no lysines accessible 
to Ltn1p but at least one lysine “hidden” in the ribosome exit tunnel. Based on our experimental 
estimates of Ltn1p’s reach (~12 amino acids) and previous measurements of the length of the 
ribosome exit tunnel (~35 amino acids) (Ban et al., 2000; Nissen et al., 2000), we estimate that 
		 16 
CAT-tailing substantially increases the fraction of RQC-degradable substrates from ~60% of 
possible nascent chains to ~95% (Fig. 9). 
 
 
Figure 9. CAT-tail-dependent degradation of endogenous RQC substrates. Fraction of 
stalling positions leading to an RQC-degradable nascent polypeptide in the presence (solid line) 
or absence (dashed line) of CAT-tails, graphed as a function of the number of amino acids 
accessible to Ltn1p and assuming a fixed exit tunnel length of 35 amino acids. The arrow shows 
the increase in RQC-degradable substrates in the presence of CAT-tails at the estimated Ltn1p 
reach of 12 amino acids. 
 
Collectively, our studies reveal an unanticipated feature of Ltn1p, the key ubiquitin ligase 
responsible for RQC-mediated degradation of incomplete nascent chains: Ltn1p is only able to 
efficiently access lysines that lie within a narrow window of the exit tunnel. This spatial 
specificity could protect the cell from collateral damage (e.g., degradation of ribosomal proteins 
or the translocation machinery, as well as unregulated quality control signaling (Higgins et al., 
2015; Juszkiewicz and Hegde, 2017)) caused by incidental ubiquitination by Ltn1p. However, 
the limited reach of Ltn1p presents a challenge to the RQC machinery that must deal with a 
diverse range of substrates. Without a mechanism to relieve this restriction on lysine positioning, 
many endogenous RQC substrates would be resistant to Ltn1p-mediated degradation. Our studies 
		 17 
reveal that, in addition to its previously described role in promoting aggregation and inducing a 
heat shock response (Choe et al., 2016; Defenouillère et al., 2016; Yonashiro et al., 2016b), 
CAT-tailing acts as a fail-safe mechanism that enables the degradation of a far broader range of 
substrates by exposing lysines sequestered in the ribosome exit tunnel (Fig. 10). 
 
Figure 10. Model for the function of CAT-tails in vivo. CAT-tails lead to aggregation in the 
presence of a compromised RQC pathway and increase lysine accessibility with an intact RQC 
complex.	
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2.4. CRISPRi screen for mammalian factors that promote accumulation of a Non-
stop decay substrate 
To systematically explore how mammalian cells cope with problematic mRNAs, we 
designed a mammalian RQC reporter that contains an open-reading frame encoding for the green 
fluorescent protein, but no stop codon (GFPNon-stop) (Fig. 11A). Since the encoded GFP lacks a 
stop codon, translation through the GFP to the end of the message causes ribosome stalling and 
subsequent degradation of the GFP nascent polypeptide via the RQC pathway. Incomplete 
proteins generated from such messages are model substrates for RQC-mediated degradation in 
yeast (Bengtson and Joazeiro, 2010) but have not been studied in mammals. Upstream of the 
GFP, the reporter encodes BFP separated by a T2A ribosome skipping sequence (Fig. 11A). As a 
result, BFP synthesis is uncoupled from RQC-mediated degradation of GFP, allowing BFP to 
serve as control for the expression levels of the reporter.  
 
Figure 11. GFPNon-stop is degraded in an RQC dependent manner. (A) Diagrams of non-stop 
stalling reporter (GFPNon-stop) and control reporters (GFPStop and GFPpolyA) (B) Median GFP:BFP 
ratio of 293T cells transiently transfected with reporter constructs containing the indicated 3’ 
mRNA sequence (median ± SD, N=3). (C)  GFP fluorescence level in cell lines stably expressing 
the GFPNon-stop reporter and control sgRNA or sgRNA against NEMF. 
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Figure 12. GFPNon-stop is a non-stop stalling reporter. (A) Ribosome occupancy measured by 
reads per million (RPM) along the GFPNon-stop reporter. (B) Relative NEMF mRNA levels 
measured by qPCR (mean ± SD, N=3). 
 
 
Since messages lacking a stop codon are rapidly degraded by the exosome (Frischmeyer 
et al., 2002) we introduced a triple helix derived from the MALAT1 non-coding RNA at the 3’ 
end to stabilize the message (Wilusz et al., 2012). Wild type cells accumulate BFP, but not GFP, 
resulting in a substantial decrease (~ 100 fold) in the GFP/BFP ratio for the GFPNon-stop reporter 
compared to two control reporters that contain either a stop codon before the MALAT1 sequence 
(GFPStop), or a stop codon and a canonical polyA tail (GFPPolyA) (Fig. 11A, B, 12A). Knockdown 
of a core RQC component, NEMF (RQC2 in yeast), led to the stabilization of GFP (Fig. 11C, 
12A), confirming the role of mammalian NEMF in degradation of nascent polypeptides resulting 
from non-stop decay mRNAs (Shao et al., 2015).  
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Figure 13. Genome-scale screen for mammalian specific RQC components (A) Workflow of 
FACS-based CRISPRi screen. Reporter cell line constitutively expressing GFPNon-stop is infected 
with the whole genome CRISPRi sgRNA library. Knockdown of genes involved in coping with 
ribosome stalling leads to GFP accumulation. GFP-positive and GFP-negative cells are sorted 
out and the sgRNAs expressed in those cells are identified via deep sequencing. (B) Volcano plot 
of GFP stabilization phenotype (log2(GFP high/GFP low) for 3 strongest sgRNAs) and Mann-
Whitney P-values from genome-scale CRISPRi FACS screen. Negative controls are shown in 
lavender, targeting guides in grey, and previously characterized RQC factors are labeled with 
unique colors. (C) Model of the mammalian RQC pathway with screen hits highlighted.  
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We next used the GFPNon-stop reporter in a fluorescence-activated cell sorting (FACS)-
based genome-wide CRISPRi screen to gain a comprehensive view of mechanisms that cells 
have for minimizing the accumulation of nascent polypeptides resulting from mRNAs lacking a 
stop codon. We engineered a K562 mammalian cell line that constitutively expresses the GFPNon-
stop reporter and the dCas9-KRAB CRISPRi effector (Gilbert et al., 2014) and transduced this cell 
line with an sgRNA library (hCRISPRi-v2) targeting all known protein-coding open reading 
frames (Horlbeck et al., 2016). We hypothesized that depletion of RQC factors will interfere 
with the ability of the cells to detect stalled ribosomes and degrade the stalled nascent 
polypeptide, which will result in GFP stabilization. We then sorted the cells with high and low 
GFP signal via FACS and identified the genes that were depleted in those cells by deep 
sequencing the sgRNAs they expressed. (Fig. 13A). The screen identified the majority of known 
components from each stage of the RQC pathway (stall detection, ribosome splitting, nascent 
chain extraction, mRNA and peptide degradation) as top hits (Fig. 13B, C, 14A, B). In addition 
to factors previously implicated in the RQC pathway, the FACS-based screen yielded several 
genes with no known RQC-related function. 
 
 
 
Figure 14. Proteasome and exosome components are hits in GFP screen. (A, B) FACS 
screen volcano plot with exosome or proteasome components highlighted in red. 
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2.5. Genetic interaction screen identifies the translation inhibitors GIGYF2 and 
4EHP as RQC components working in parallel to nascent polypeptide degradation 
by NEMF 
To differentiate between factors that allow mammalian cells to cope with stalled 
ribosomes as part of the RQC from components of parallel proteostasis pathways, we 
complemented our reporter-based screen with a growth-based CRISPRi genetic interaction (GI) 
screen. We aimed to search for components that have synergistic growth defects in combination 
with loss of NEMF. This idea was motivated in part by recent findings that combined loss of the 
NEMF homolog in bacteria (RqcH) and the tmRNA/ ssrA pathway, which helps dispose of 
incomplete translation products, leads to a synergistic growth defect. (Lytvynenko et al., 2019). 
To test whether similar pathways exist in combination with the mammalian RQC pathway, we 
took advantage of the growth defect caused by NEMF depletion (Fig. 15A). We engineered a 
cell line constitutively expressing a NEMF-targeting sgRNA, as well as a paired cell line 
constitutively expressing a non-targeting control sgRNA, and infected both cell lines with the 
genome-wide CRISPRi sgRNA library (Fig. 15B). We determined the change in the sgRNA 
abundance over 10 doublings for each cell lines and then compared this change between the two 
cell lines. We expected that depletion of RQC components will have similar effect on growth 
alone or in combination with NEMF knockdown (buffering interaction) (Fig. 15C). On the other 
hand, disruption of pathways that work in parallel with RQC to prevent the accumulation of 
failed translation products is expected to exacerbate the growth phenotype caused by loss of 
NEMF (synergistic interaction). Indeed, the screen revealed several factors that exhibit buffering 
or synergistic growth interactions with loss of NEMF (Fig. 15D).  
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Figure 15. CRISPRi genetic interaction screen for factors that affect the growth of NEMF 
knockdown cells. (A) Competition assay between cells expressing a control or NEMF targeting 
sgRNA. (B) Workflow of growth-based CRISPRi screen. Control knockdown or NEMF 
knockdown cell lines were infected with the genome-scale sgRNA library and the change in the 
sgRNA abundance between the two cell lines following 10 cell doublings was determined by 
deep sequencing. (C) Expected growth phenotypes and predicted biological pathways resulting 
from knockdown of a hypothetical factor (X) alone or in combination with NEMF. (D) Results 
from genetic interaction (GI) screen for factors affecting the growth of control or NEMF 
knockdown cells. GI scores were derived by fitting the data to a quadratic curve (red dashed line) 
and calculating the distance of each point from the best-fit line. Genes exhibiting synergistic 
interactions with NEMF knockdown vs. control knockdown (negative GI score) are marked in 
blue, and genes with positive GI score (buffering interactions) are in yellow. (E) Comparison of 
FACS and GI CRISPRi screens. Hits from FACS screen (log2 enrichment > 1) that stabilized 
GFPnon-stop reporter upon individual re-testing are labeled and colored by GI score. 
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We then compared the hits from the FACS-based reporter screen and the modifier screen. 
Two genes stood out as having both a strong synergistic interaction with loss of NEMF and 
stabilizing effect on the RQC reporter upon knockdown: PATL1 and GIGYF2 (Fig. 15E). PATL1 
encodes a scaffold protein that bridges mRNA decapping and deadenylation (Ozgur et al., 2010). 
Stabilization of damaged mRNAs in the absence of PATL1 could explain both the increased 
levels of stalled nascent polypeptides and the synergistic growth interaction with NEMF 
knockdown, which disposes of incomplete protein products from such damaged mRNAs. We 
focused our attention on the second gene, GIGYF2, which had not been previously implicated in 
the cellular response to damaged mRNAs.  
Overexpression studies of tagged GIGYF2 have shown that it interacts with the inhibitory 
cap-binding protein 4EHP (Peter et al., 2017) and the ribosome collision sensor ZNF598 (Morita 
et al., 2012; Tollenaere et al., 2019). Indeed, 4EHP and ZNF598 co-immunoprecipitated with 
GIGYF2 endogenously tagged with GFP11, confirming that these three proteins interact in cells 
(Fig. 16A). In addition, GIGYF2 and 4EHP were strongly enriched upon immunoprecipitation of 
FLAG- tagged ZNF598, as quantified by mass spectrometry (Fig. 17).  
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Figure 16. GIGFY2 and 4EHP are components of a pathway parallel to the RQC. (A) 
Immunoprecipitation (IP) and immunoblot (IB) for endogenously tagged GIGYF2, and its 
binding partners, ZNF598 and 4EHP. (B) Outline of growth competition experiments. K562 cells 
were infected with RFP labeled construct carrying two sgRNAs (targeting + control or two 
targeting guides). The abundance of RFP positive cells is measured over time via flow 
cytometry. (C) Competition assay among cells expressing sgRNA targeting GIGYF2 and NEMF 
alone or in combination (mean ± SD, N=2). Dotted grey line highlights the expected growth 
phenotype and the black line represents the observed growth defect of the double knockdown 
cells. The deviation from the expected phenotype is indicative of synergistic growth interaction. 
(D) Competition assay of double knockdown cell lines. The bar graph represents the difference 
in the measured (actual) growth defect and expected phenotype (additive value of single growth 
defects) on day 16 of the competition assay.  
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Figure 17. GIGYF2 and 4EHP are top interactors of ZNF598. Ranked proteins identified via 
mass-spectrometry after 3FLAG-ZNF598 immunoprecipitation (mean ± SD, N=3). 
 
Although an interaction between GIGYF2 and ZNF598 has been reported, the role of 
GIGYF2 and 4EHP in ribosome-associated quality control has not been explored. Based on our 
GI screen, knockdown of GIGYF2 or 4EHP in combination with knockdown of NEMF leads to a 
synergistic growth defect. This result suggests that GIGYF2 and 4EHP function in parallel to the 
RQC pathway to counter accumulation of toxic polypeptides resulting from ribosome stalling. 
We were able to recapitulate the GI screen results in targeted studies (Fig. 16B, C). The 
moderate growth phenotype imparted by knockdown of NEMF was exacerbated by GIGYF2 
knockdown (Fig. 16C). Similarly, 4EHP knockdown also had a synergistic interaction with 
NEMF knockdown, suggesting that GIGYF2 and 4EHP work in parallel to NEMF. In addition, 
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ZNF598 knockdown had buffering interactions with GIGYF2 and 4EHP (Fig. 16D, 18A, B) 
consistent with the data that these three proteins form a complex and work together in the same 
pathway.  
 
 
Figure 18. GIGYF2 and 4EHP have a synergistic growth interaction with loss of NEMF. 
(A) Relative mRNA levels for NEMF, GIGYF2, 4EHP, and ZNF598 upon knockdown measured 
by qPCR (mean ± SD, N=3). (B) Competition assays between control cells and cells harboring a 
single or double knockdown of NEMF, ZNF598, GIGYF2, and 4EHP.  
 
 
 
 
 
 
 
		 28 
 
2.6. GIGYF2, 4EHP, and ZNF598 inhibit translation of faulty mRNAs 
4EHP (EIF4E2) is an ortholog of the mRNA cap-binding and translation initiation factor 
EIF4E1. However, 4EHP cannot bind EIF4G and as a result it blocks assembly of productive 
EIF4F initiation complex (Rom et al., 1998; Zuberek et al., 2007), thereby repressing translation 
of the bound mRNA. Indeed, recruitment of GIGYF2 or 4EHP to reporter messages has been 
shown to block translation initiation (Kryszke et al., 2016; Morita et al., 2012). It has been 
hypothesized that GIGYF2 requires an adapter protein for recruitment to its target mRNA, 
although the endogenous substrates and recruitment factors remain incompletely characterized. 
Our genetic and biochemical studies suggest a model in which ZNF598 could act as one such 
factor that recruits GIGYF2 and 4EHP to messages harboring stalled ribosomes, which 
ultimately leads to translational silencing of the mRNA.  
To test this model, we measured the effect of knocking down these proteins on the 
GFPNon-stop fluorescent reporter. We compared the levels of BFP, which is released before 
stalling and is, therefore, a readout of the reporter expression levels, and GFP, which is degraded 
due to ribosome stalling (Fig. 19A). As expected, knockdown of NEMF, a factor involved in the 
degradation of the stalled nascent polypeptide, increased GFP, but not BFP levels. Knockdown 
of GIGYF2 or 4EHP, however, increased the levels of both fluorescent proteins (Fig. 19A) 
without affecting reporter mRNA levels (Fig. 19B), or protein half-life (Fig. 20) supporting the 
hypothesis that these two factors are translation inhibitors.  
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Figure 19. GIGYF2 and 4EHP selectively inhibit translation of faulty messages harboring 
stalled ribosomes. (A) BFP and GFP fold change upon knockdown of various RQC factors 
measured by flow cytometry (median ± SD, N=3). (B) Relative GFPNon-stop reporter mRNA 
levels measured by qPCR upon RQC factors knockdown (mean ± SD, N=3). (C) Translation 
efficiency (TE) of GFP non-stop reporter in knockdown cell (bar plot represents the mean, with 
data points shown, N=2). (D) Histogram of TE change in GIGYF2 knockdown compared to 
control. GFPNon-stop reporter is highlighted with a red line. 
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Figure 20. Reporter protein half-life is unaffected by knockdown of RQC factors. BFP 
fluorescence measured after addition of cycloheximide (100 mg/ul) in various knockdown cell 
lines.  
 
 
 
 
 
To directly measure the changes in ribosome occupancy on our GFPNon-stop stalling 
reporter, we performed ribosome profiling. Consistent with the fluorescent reporter assay, the 
translation efficiency (TE) of the reporter was increased in both GIGYF2 and 4EHP knockdown 
cell lines (Fig. 19C), with minimal changes in the reporter mRNA expression levels (Fig. 21A). 
When compared to endogenous messages with similar expression levels, the GFPNon-stop reporter 
has one of the highest TE changes upon loss of GIGYF2 (Fig. 19D, 21B). In addition, we find 
that the TE of endogenous messages is not affected by GIGYF2 or 4EHP knockdown, regardless 
of their expression levels (Fig. 21C, D). Taken together, these data support a model where 
GIGYF2/4EHP block translation on problematic messages.  
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Figure 21. GIGYF2 and 4EHP block translation initiation on faulty mRNAs. (A) mRNA 
levels of GFPNon-stop reporter in knockdown cell lines. (B) Translation efficiency (TE) change for 
endogenous genes and GFPNon-stop stalling reporter (red dot) in GIGYF2 knockdown vs. control 
cells. (C, D) TE of endogenous mRNAs binned by mRNA expression level in GIGYF2 or 4EHP 
knockdown cells.  
 
To ensure that the observed translational effect was specific to faulty mRNAs, and not 
due to global changes in protein production, we used a second set of reporters with bidirectional 
promoters. One promoter drives expression of an mRNA coding for GFP with a canonical stop 
codon and polyA tail, and the other drives a non-stop reporter (RFPNon-stop) or a control 
fluorescent protein (RFPStop) on a separate mRNA. Importantly, these cell lines have similar 
expression levels for the stalling and non-stalling reporters as confirmed by qPCR (Fig. 23A, B).  
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Figure 22. GIGYF2 and 4EHP selectively inhibit translation of multiple faulty messages 
without global effects on translation. (A) Bidirectional promoters were used to express GFP 
with stop codon and polyA tail, and RFP with or without stop codon (diagramed above). 
Cumulative distribution plot of RFP/GFP protein ratios measured by flow cytometry in RQC 
knockdown cells lines. Cells expressing RFPNon-stop reporters are shown as solid lines, whereas 
cells harboring RFPstop are shown as dashed lines. (B) Cumulative distribution plot of GFP 
protein levels measured by flow cytometry in RQC knockdown cells lines. Solid and dashed 
lines represent GFP signal from reporter also containing RFPNon-stop or RFPstop respectively. (C) 
BFP and GFP protein fold change of K20 stalling reporter upon RQC factors knockdown 
(median ± SD, N=2). (D) Cells expressing GFPNon-stop reporter were treated with the proteasome 
inhibitor Bortezomib for 3h and the BFP and GFP protein stabilization was measured by flow 
cytometry (median ± SD, N=2).  
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Knockdown of NEMF, GIGYF2, and 4EHP increased the RFP/GFP ratio for RFPNon-stop, but not 
RFPStop (Fig. 22A). These knockdowns did not have a global effect on translation as the levels of 
the non-stalling controls were unchanged (Fig. 22B, 23C-F). The observed RFPNon-stop 
stabilization was not due to changes in mRNA levels (Fig. 23G), consistent with the GFPNon-stop 
reporter used in our original screen. In addition, a simultaneous knockdown of NEMF and 
GIGYF2 increased the RFP/GFP ratio to a greater extent than either single knockdown, further 
suggesting that these factors are components of two parallel pathways coping with ribosome 
stalling.  
We confirmed that the observed translational silencing does not depend on the type of 
stall by measuring the effect of GIGYF2 and 4EHP knockdown on a fluorescent reporter 
containing a previously characterized mammalian stalling sequence, 20 AAA (K20) 
(Juszkiewicz and Hegde, 2017). Similar to the GFPNon-stop reporter, knockdown of GIGYF2 or 
4EHP led to an increase in both GFP and BFP fluorescence levels (Fig. 22C), without a change 
in mRNA levels (Fig. 23H). In the case of ZNF598, however, knockdown led to the increase of 
GFP, but not BFP, indicating that the requirement for ZNF598 is specific to the Non-stop 
substrate, whereas alternative factors may be required to recruit GIGYF2 and 4EHP to No-Go 
mRNAs. Intriguingly, prior to the discovery of the RQC pathways, it had been suggested that the 
lack of a stop codon can interfere with translation of a message (Akimitsu et al., 2007). However, 
the relationship (if any) between that phenomenon, which was believed to act in a post-initiation 
step resulting in halting of translation before completion of full-length proteins, and the 
GIGYF2/4EHP-mediated inhibition of translation of Non-stop and No-Go substrates is unclear. 
 
		 34 
 
Figure 23. GIGYF2 and 4EHP selectively inhibit translation of faulty mRNAs. (A) Diagram 
of RFPNon-stop (NS) and RFPstop (Ctrl) bidirectional reporters. (B) Relative RFP mRNA levels 
measured by qPCR (mean ± SD, N=3) from cells stably expressing the NS or Ctrl reporters. (C-
F) GFP or RFP fluorescence of NS or Ctrl reporter in various knockdown cell lines measured by 
flow cytometry. (G) Relative RFP/GFP mRNA levels in NS or Ctrl reporter cell lines in various 
knockdown backgrounds measured by qPCR (mean ± SD, N=3). (H) Relative GFP mRNA 
levels for K20 reporter in knockdown cell lines. 
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Finally, to confirm that GIGYF2 and 4EHP are part of a pathway that works in parallel to 
RQC-mediated degradation of the stalled nascent polypeptide, we inhibited the proteasome by 
treating various knockdown cell lines with bortezomib (Fig. 22D). We observed stabilization of 
the stalled polypeptide in the GIGYF2, 4EHP and ZNF598 knockdown cells lines of the same 
magnitude as cells expressing a control sgRNA, whereas, knockdown of NEMF leads to a much 
milder increase upon bortezomib treatment, consistent with the role of NEMF in UPS-mediated 
nascent chain degradation. This result indicates that the observed increase in fluorescence upon 
GIGYF2 and 4EHP knockdown is not caused by nascent chain stabilization, but by increased 
ribosome engagement, and that the partially synthesized polypeptide is still targeted for 
degradation by RQC.  
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2.7. The yeast homologs of GIGYF2, Smy2p and Syh1p, destabilize faulty mRNAs  
We next explored whether GIGYF2 and/or 4EHP played a role in RQC in yeast. Two 
potential homologs of GIGYF2 have been identified in yeast, Smy2p and Syh1p (Ash et al., 
2010), although they have not been implicated in RQC. To determine if Smy2p and Syh1p play a 
role in preventing accumulation of incomplete polypeptides, we utilized a previously 
characterized yeast stalling reporter (D’Orazio et al., 2019). This reporter expresses a no-go 
substrate and a control fluorescent protein from a bidirectional promoter. The stalling substrate 
encodes GFP separated by a T2A ribosome skipping sequence from HIS3 gene containing an 
internal stretch of non-optimal codons (CGA12). As a control, we used a similar reporter without 
the CGA12 stalling sequence. We compared the protein levels by flow cytometry and found that 
knockout of SMY2 and SYH1 alone led to an increase in the GFP/RFP ratio (Fig. 24A). Deleting 
both homologs led to a greater increase in GFP/RFP compared to the single deletions, suggesting 
that Smy2p and Syh1p have redundant function. This redundancy could account for the lack of 
identification of these factors in early RQC screens. Importantly, similar to the human homologs, 
deletion of the GYF-containing proteins had no effect on global translation. However, in contrast 
to the mammalian system, the increased expression of the reporter was accompanied by mRNA 
stabilization of the stalling mRNA, but not control mRNA (Fig. 24B). This observation is 
consistent with the apparent lack of a 4EHP homolog in yeast, which is an essential part of the 
mechanism of translation inhibition in mammals. Indeed, the yeast GIGYF2 homologs lack the 
4EHP binding domain found in human GIGYF2 (Fig. 24C). However, Smy2p has been shown to 
bind Eap1p, a protein implicated in mRNA decapping and degradation (Ash et al., 2010). These 
data suggest that the role GIGYF2-like proteins play in RQC preceded the last common ancestor 
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of yeast and mammals. Recruitment of GIGYF2 leads to translational silencing in higher 
eukaryotes, whereas Smy2p and Syh1p mediate RNA decay in yeast.  
 
 
 
Figure 24. The yeast homologs of GIGYF2, Smy2p and Syh1p, are RQC factors. (A) 
Schematic of control (ctr) reporter and no-go decay (NGD) reporter containing a stretch of 12 
non-optimal CGA codons in the middle of the HIS3 open reading frame (top). Box plot of 
GFP/RFP ratios for NGD or control reporter levels in knockout yeast strains measured by flow 
cytometry (bottom). (B) Relative mRNA levels for ctr or NGD reporter in wild type or knockout 
strains measured by qPCR (mean ± SD, N=3). (C) Alignment of regions of GIGYF2, Syh1p, and 
Smy2p highlighting the 4EHP-binding and GYF domains.  
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2.8. Recruitment of GIGYF2, 4EHP and ZNF598 leads to translation inhibition 
Our genetic and biochemical data suggest that mammalian GIGYF2 and 4EHP can be 
recruited to problematic messages by the ubiquitin ligase ZNF598 (Juszkiewicz and Hegde, 
2017; Sundaramoorthy et al., 2017). To explore this hypothesis, we used an MS2-based system 
to tether ZNF598, GIGYF2, or 4EHP to a reporter mRNA (Bertrand et al., 1998) (Fig. 25A). We 
transiently co-expressed a non-stalling reporter (GFPMS2-stop) harboring three MS2 stem-loops in 
its 5’ UTR together with MS2 binding protein (MS2BP) fusions in HEK293T cells. Consistent 
with published data, recruitment of GIGYF2 or 4EHP to the reporter led to inhibition of 
translation (Kryszke et al., 2016), as evidenced by a robust decrease in GFP fluorescence without 
significant changes in the mRNA levels (Fig. 25B, C, 26A). The translation level was not 
strongly inhibited by MS2BP recruitment alone (Fig. 25B), or overexpression of a FLAG-tagged 
GIGYF2 protein that does not get recruited to the reporter (Fig. 26B, C), indicating that the 
observed translational silencing was specific for the tethering of the factors to the mRNA. 
Additionally, recruitment of ZNF598 to the reporter induced similar translational silencing. 
 
Figure 25. Recruitment of ZNF598, GIGYF2 and 4EHP inhibit translation. (A) Schematic 
of MS2-mediated recruitment of putative silencing factors to a fluorescent reporter. (B) GFP 
fluorescence of GFPMS2-stop reporter transiently expressed in HEK293T cells alone or with 
MS2BP-fusion proteins. (C) GFP fluorescence of K562 cells stably expressing GFPMS2-stop 
reporter alone or in combination with MS2BP-fusion proteins. 
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Figure 26. GIGYF2, 4EHP, and ZNF598 inhibit translation when directly recruited to an 
mRNA. (A, D) Relative mRNA levels of GFPMS2-Stop reporter upon transient or stable expression 
of MS2BP-fusion proteins measured by qPCR (mean ± SD, N=3). (B, C) Protein and mRNA 
levels of GFPMS2-Stop measured by flow cytometry or qPCR upon transient expression of 
3xFLAG-GIGYF2, that is not directly recruited to the reporter (mean ± SD, N=3). (E) MS2BP-
fusion proteins expression levels upon stable integration in K562 dCas9-KRAB cells measured 
by RFP fluorescence.  
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2.9. Translational inhibition by ZNF598 is mediated by GIGYF2 and 4EHP in a 
ubiquitination- independent manner 
To explore the genetic requirements for translation inhibition, we generated stable cell 
lines expressing an MS2-fusion protein, as well as GFPMS2-stop reporter, and CRISPRi machinery 
(Fig. 25C, 26D). We used CRISPRi to knock down ZNF598, GIGYF2, or 4EHP and measured 
the effect of the knockdown on GFP levels via flow cytometry. Knockdown of GIGYF2 or 4EHP 
alleviated the decrease in GFP fluorescence caused by MS2-ZNF598 (Fig. 27A, 28A-H). Lower 
expression of the MS2BP-GIGYF2 fusion protein in K562 cells resulted in an attenuated 
repression phenotype compared to HEK293T (Fig. 26E). Nonetheless, the GIGYF2-mediated 
repression depended on 4EHP. Similarly, 4EHP-mediated repression depended on GIGYF2, 
suggesting that these two factors act together to mediate translation inhibition (Fig. 27A). In 
marked contrast, silencing by neither GIGYF2, nor by 4EHP was impacted by knockdown of 
ZNF598 when these factors were directly recruited to the mRNA, indicating that GIGYF2 and 
4EHP work downstream and independently of ZNF598. These epistasis experiments support a 
model in which ZNF598 serves as a scaffold that can recruit GIGYF2 and 4EHP to faulty 
mRNAs (Fig. 27B).  
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Figure 27. Translational inhibition by ZNF598 is mediated through GIGYF2 and 4EHP in 
a ubiquitination-independent manner. (A, D) MS2-fusion protein is recruited to the GFPMS2-
stop reporter in control cells or knockdown cells for ZNF598, GIGYF2 or 4EHP. The effect of the 
knockdown on the ability of the fusion protein to silence translation from the reporter is 
measured via the change in GFP fluorescence. (B) Model for GIGYF2 and 4EHP recruitment to 
mRNA by ZNF598. (C) GFP fluorescence from GFPMS2-stop reporter upon MS2-mediated 
recruitment of wild type or ubiquitination incompetent ZNF598 (ZNF598C29A or ZNF598DRING). 
 
 
ZNF598 recognizes collided stalled ribosomes and ubiquitinates the small subunit of the 
ribosome, which triggers ribosome splitting and subsequent RQC complex engagement (Ikeuchi 
et al., 2019; Juszkiewicz et al., 2018). We next tested whether ZNF598-mediated ubiquitination 
is required for translational repression by GIGYF2 and 4EHP. We generated ubiquitination-
deficient MS2BP-ZNF598 fusion proteins that harbored inactivating mutations in the RING 
domain (C29A) or deletions of the entire domain (ΔRING) (Sundaramoorthy et al., 2017) and 
compared their ability to translationally silence the GFPMS2-stop reporter. Surprisingly, both 
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mutants were capable of repressing translation (Fig. 27C, 29A). Recruitment of a stably 
integrated MS2BP-ZNF598ΔRING also repressed translation in a GIGYF2 and 4EHP-dependent 
manner matching the recruitment of wild-type ZNF598. (Fig. 27D, 29B). These data suggest that 
ZNF598 has a dual function when it engages collided ribosomes. It serves as a ubiquitin ligase 
that mono-ubiquitinates the 40S small subunit, triggering release of the stalled ribosome and 
subsequent RQC engagement, and nascent polypeptide degradation (Juszkiewicz et al., 2018; 
Sundaramoorthy et al., 2017). In addition, ZNF598 also serves as a scaffold that provides one 
mechanism for the recruitment of GIGYF2 and 4EHP to the mRNA, in a ubiquitination-
independent manner. Once recruited, GIGYF2 and 4EHP sequester the mRNA cap, blocking 
ribosome initiation and decreasing the translational load on problematic messages.  
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Figure 28. ZNF598 mediated translation inhibition requires GIGYF2 and 4EHP. (A - C) 
Relative mRNA levels upon control (Gal4) or targeting (ZNF598, GIGYF2, 4EHP) knockdown 
in cells stably expressing GFPMS2-Stop reporter (mean ± SD, N=3). (D - F) Relative GFPMS2-Stop 
reporter mRNA levels in knockdown cell lines upon MS2-fusion protein recruitment (mean ± 
SD, N=3). (G) GFPMS2-Stop reporter proteins expression levels measured by GFP fluorescence 
upon control, GIGYF2, 4EHP, or ZNF598 knockdown. (H) Relative MS2BP-fusion proteins 
expression levels measured by RFP fluorescence upon control, GIGYF2, 4EHP, or ZNF598 
knockdown.  
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Figure 29. ZNF598 mediated translation inhibition is ubiquitination independent. (A) 
Relative mRNA levels of GFPMS2-Stop reporter upon MS2BP-ZNF598 (wt, C29A, DRING) 
recruitment (mean ± SD, N=3). (B) Relative mRNA levels of GFPMS2-Stop reporter in knockdown 
cell lines upon MS2BP-ZNF598 (wt and DRING) fusion protein recruitment (mean ± SD, N=3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
		 45 
2.10. GIGYF2 and 4EHP can be recruited to faulty mRNAs in a ZNF598-
independent manner. 
The translation phenotype of ZNF598 knockdown is consistently weaker than that seen 
with GIGYF2 knockdown alone for Non-stop substrates (Fig. 30A) and ZNF598, unlike 
GIGYF2, does not have a translational effect on our No-go reporter (Fig. 22C). Moreover, when 
GIGYF2 is knocked down, additional depletion of ZNF598 has no effect on the increased 
translation of the GFPNon-stop reporter (Fig. 30A, 32A). This phenomenon is recapitulated by the 
artificial tethering experiments using MS2; ZNF598 relies on GIGYF2 or 4EHP for translation 
repression, but GIGYF2 and 4EHP do not require ZNF598 for translational repression when 
directly recruited to the message.  
 
 
Figure 30. GIGYF2 does not depend on ZNF598 for translation repression. (A) BFP and 
GFP fold change upon single or double RQC factors knockdown measured by flow cytometry 
(median ± SD, N=2). 
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These observations can be explained by the presence of alternative recruitment 
mechanisms for GIGYF2 and 4EHP to faulty mRNAs, or by technical limitations, such as 
incomplete ZNF598 knockdown. Although we achieved over 95% knockdown of ZNF598 via 
CRISPRi (Fig. 31B, 32B), we could not exclude the possibility that the remaining ZNF598 is 
responsible for the observed partial phenotype.  
To differentiate between these two hypotheses, we engineered a ZNF598 knockout cell 
line using CRISPR/Cas9 and confirmed that these cells are true knockouts both by western 
blotting (Fig. 31B, 32B) and sequencing of the genomic locus (Canaj et al., 2019). We integrated 
the GFPNon-stop reporter in these cells and measured the effect of GIGYF2 and 4EHP knockdown 
on the GFP and BFP levels.  
 
Figure 31. ZNF598-dependent and independent pathways for GIGYF2-4EHP recruitment 
and RQC. (B) Immunoblot (IB) of ZNF598 in wildtype, ZNF598 knockdown, and ZNF598 
knockout cell lines. (C) BFP and GFP fold change upon RQC factors knockdown in a ZNF598 
knockout cell line measured by flow cytometry (median ± SD, N=2).  
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Figure 32. GIGYF2 and 4EHP can be recruited to damaged messages in a ZNF598-
independent manner. (A) Schematic of double knockdown vector (top). Relative mRNA levels 
of GFPNon-stop reporter upon single or double knockdown (mean ± SD, N=3). (B) Western blot of 
ZNF598 knockout clones, as well as cell expressing endogenous wild type ZNF598 (WT) or 
ZNF598 knockdown cells (KD). GAPDH is used as a loading control. KO_6* was selected for 
further experiments. 
 
Knocking down these factors led to an increase in both the GFP and BFP fluorescent signals, 
even though no ZNF598 is present in these cells (Fig. 31C). Importantly, knockdown of ZNF598 
in the knockout cells had no effect on the stalling reporter, confirming the specificity of the 
CRISPR knockdown. This experiment supports the existence of ZNF598-independent 
recruitment mechanism(s) that enable GIGYF2 and 4EHP to inhibit translation of damaged 
messages (Fig. 33) 
		 48 
 
 
Figure 33. Model of translation shut-off upon ribosome stalling. Ribosome collision is 
detected by the collision sensor ZNF598. Its binding triggers a cascade of events that ultimately 
leads to the release of the stalled ribosome, and the degradation of the faulty mRNA and stalled 
nascent peptide. In addition, ZNF598 recruits the translation inhibitors GIGYF2 and 4EHP to the 
defective message, which blocks further ribosome initiation. Recruitment of GIGYF2 and 4EHP 
to defective messages could be mediated by factors other than ZNF598.  
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3. DISCUSSION 
The cell faces an inherent challenge in detecting problematic mRNAs in that it is only 
through the act of translation itself that the lesion can be recognized, and failure of this 
recognition results in cytotoxicity. Our work reveals a novel mechanism in which failed 
translation leads to inhibition of further translation initiation on that message. This pathway acts 
in parallel with previously described quality control pathways, which trigger mRNA degradation, 
ribosome release, and proteasomal degradation of the stalled nascent polypeptide. Without a 
mechanism to block further initiation on problematic messages, translation of faulty mRNAs 
would continue for as long as the message persists. GIGYF2 and 4EHP enable the cell to break 
this cycle by allowing a failed translation event to initiate a specific negative feedback loop 
which shuts down further translation of the message. Although GIGYF2 and 4EHP have been 
implicated in translational control in a number of different settings (Amaya Ramirez et al., 2018; 
Fu et al., 2016; Kryszke et al., 2016; Morita et al., 2012; Peter et al., 2017; Tollenaere et al., 
2019), our data argue that faulty mRNAs that cause ribosome stalling comprise an important 
subset of endogenous substrates for GIGYF2 and 4EHP mediated repression. Indeed, loss of 
GIGYF2 specifically increases translational output from two distinct classes of stalling reporters. 
Moreover, knocking down GIGYF2 in combination with loss of RQC components had a strong 
synergistic growth interaction in the absence of a reporter, suggesting that there is a continuous 
production of endogenous stalling substrates that engage RQC.  
How then are stalled ribosomes recognized and how is GIGYF2 recruited? Recruitment 
of GIGYF2 and 4EHP to their endogenous substrate is hypothesized to occur via sets of auxiliary 
RNA binding proteins that serve as adapters. Our data argue that ZNF598 can serve as one such 
adapter to recruit the inhibitory complex to defective messages. However, GIGYF2 and 4EHP 
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are still capable of repressing translation initiation on faulty mRNAs even in a ZNF598 null 
background (Fig. 7B, C). These data suggest that there are both ZNF598-dependent and 
ZNF598-independent mechanisms for recruitment of GIGYF2 and 4EHP to mediate translation 
inhibition on defective messages (Fig. 7D). The identity of these additional adapters and whether 
they are redundant with ZNF598, activated or expressed as a compensatory mechanism upon 
ZNF598 loss, or act on specific classes of faulty mRNAs remains to be explored.  
How is translation initiation inhibited? Since 4EHP is a cap binding protein, one might 
naively expect that GIGYF2 and 4EHP will exclusively affect cap-dependent translation. 
However, further considerations suggest that GIGYF2 and 4EHP may have a broader effect on 
translation. For example, GIGYF2 contains a Glycine/Tryptophan (GW)-rich motif that has been 
shown to facilitate phase transition (Sheu-Gruttadauria and MacRae, 2018). Thus, an attractive 
hypothesis is that upon stalling, messages bound by GIGYF2 are sequestered away in an 
inhibitory environment that further interferes with translation, in addition to the direct inhibitory 
effect of 4EHP-mediated cap sequestration. In support of this hypothesis, using single mRNA 
imaging in live cells Moon and colleagues (Moon et al., 2020) observed that messages that 
contain stalled ribosomes can partition into stress granules under different cellular conditions. As 
a result, the molecular mechanism by which GIGYF2 and 4EHP mediate translational repression 
upon ribosome stalling is likely multidimensional and remains to be fully explored.  
Regardless of their recruitment or silencing mechanism, our data establish a critical role 
for GIGYF2 and 4EHP in inhibiting translation initiation on defective mRNAs. The synergistic 
growth defects with core RQC components highlight the importance of these two factors in 
preventing accumulation of incomplete proteins. Loss of GIGYF2 has been associated with 
neurodegenerative and neurodevelopmental phenotypes (Krumm et al., 2015; Thyme et al., 
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2019), similar to loss of RQC components (Chu et al., 2009). It is tempting to speculate that 
dysregulation of the GIGYF2/4EHP pathway increases the burden on the proteostasis network in 
neurons. As these cells age, they can either accumulate defective mRNAs or become less 
efficient in detecting and/or coping with stalled ribosomes. If these cells lack functional GIGYF2 
and 4EHP to translationally silence such defective messages, the increased stalling burden may 
overwhelm the RQC pathway in cells leading to cell stress and neurodegenerative disease.  
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4. MATERIALS AND METHODS 
 
4.1. Yeast Strains 
All strains used in this study are listed in Table 1. Strain BY4741 was used as the wild-
type parental strain. Genomic knockouts were generated by one-step gene replacement. The 
knockouts were confirmed by genomic PCR. Rqc2pmut strain was generated by replacing the 
endogenous RQC2 open reading frame with the mutant version via scarless pop-in/pop-out 
method. Stalling constructs (GFP20Lys, GFPLys-free, XTEN0-80, His3Lys-free) were expressed on 
yeast centromeric plasmids. Rqc2p constructs were overexpressed from yeast episomal plasmids. 
 
4.2. Immunoprecipitation and western blot in yeast 
Cells were grown to final OD600 between 0.6 and 1 and harvested by centrifugation. The 
pellets were washed once in water and resuspended in yeast lysis buffer (10 mM Tris pH7.5, 150 
mM NaCl, 0.5 mM EDTA, 0.5% NP-40, 1X HaltTMProtease Inhibitor Cocktail (Thermo Fisher 
Scientific)). An equal volume of glass beads (BioSpec, 0.5 mm, acid washed) was added to the 
cells and the cells were lysed by vortexing for 1 min and chilling on ice for 1 min, five times 
total. The lysate was clarified by centrifugation at 20,000 g for 2 min. Protein concentration was 
measured with BCA Assay (Thermo Fisher Scientific).  
Cell lysates were denatured at 70°C for 10 min in 1X Laemmli buffer with β-
Mercaptoethanol (BME). Proteins were separated on Bolt® 4-12% Bis-tris gels (Thermo Fisher 
Scientific), transferred to nitrocellulose membrane using the Trans-Blot® Turbo™ Transfer 
System (Bio-Rad) according to the manufacturer’s instructions, blocked with 5% milk in TBS, 
and subsequently probed. The HA epitope tag was detected using the high-affinity rat anti-HA 
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antibody (Roche 3F10, 1:1,000 dilution). The FLAG epitope tag was detected using the high-
affinity mouse anti-FLAG antibody (Sigma F1804, 1:3,000 dilution). Hexokinase was detected 
using the rabbit anti-hexokinase antibody (United States Biological H2035-02,	1:10,000 
dilution). Licor IRDye700 anti-mouse (Odyssey), IRDye800/IRDye700 anti-rabbit (Odyssey), or 
IR800 anti-rat (Rockland) secondary antibodies were then used at 1:10,000 dilution. All blots 
were visualized using the Licor (Odyssey) system. ImageJ was used for protein quantification. 
All samples were normalized to Hexokinase loading control. 
 
4.3. in vivo ubiquitin assay  
Myc-tagged ubiquitin was expressed ectopically under a copper-inducible promoter 
(Table 2). Yeast cells were grown for 2 h in the presence of 200 μM Cu2SO4 to induce Myc-
Ubiquitin expression. MG132 proteasome inhibitor was added at 60 μM final concentration. 
After 1 h, cells were harvested via centrifugation. Yeast cells were treated with 0.1 M NaOH for 
5 min at room temperature, pelleted, resuspended and boiled in the presence of 1% SDS, 50 mM 
Tris-HCl pH 7.5, 5 mM EDTA, 5 mM N-ethylmaleimide (NEM) and 1X HaltTM Protease 
Inhibitor Cocktail (Thermo Fisher Scientific). 100 μl of boiled lysate was further diluted with 
900 μl of IP buffer (50 mM Tris-HCl pH 7.5, 250 mM NaCl, 5 mM EDTA, 0.5% NP40, 1 mM 
NEM), and incubated with 25 ul bead-conjugated anti-Flag antibody (Anti-FLAG® M2 
Magnetic Beads, Sigma-Aldrich) or 20 ul bead-conjugated anti-HA antibody (PierceTM Anti-HA 
Magnetic Beads, Thermo Fisher Scientific) for 2 h at room temperature. After three washes in IP 
buffer, beads were boiled in 2X Laemmli Buffer with no BME, and the eluates were used for 
immunoblot.  
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4.4. Mammalian cell culture and cell line generation  
K562 cells were grown in RPMI-1640 with 25mM HEPES, 2.0 g/L NaHCO3, 0.3 g/L L-
Glutamine supplemented with 10% FBS, 2 mM glutamine, 100 units/mL penicillin and 
100 μg/mL streptomycin. HEK293T cells were grown in Dulbecco’s modified eagle medium 
(DMEM) in 10% FBS, 2 mM glutamine, 100 units/mL penicillin and 100 μg/mL streptomycin.  
Reporter constructs (GFPNon-stop, GFPStop, GFPPolyA, K20, RFPNon-stop, RFPStop, GFPMS2-stop, 
MS2BP, MS2BP-ZNF598, MS2BP-GIGYF2, MS2BP-4EHP) were stably transduced into K562 
CRISPRi cell line (Horlbeck et al., 2016) using Piggy-Bac transposition (System Biosciences 
PB210PA-1 and corresponding Piggy-Bac expression vector Table 4). Positive cells were 
isolated by FACS on a BD FACSAria2.  
Transient expression of reporters (GFPNon-stop, GFPStop, GFPPolyA, MS2BP, MS2BP-
ZNF598, MS2BP-GIGYF2, MS2BP-4EHP) was achieved by transfecting HEK293T cells with 
vectors from Table 4 using TransIT-LTI Transfection Reagent (Mirus, MIR 2306) according to 
the manufacturer’s instructions.  
Individual gene knockdowns were carried out by selecting sgRNA protospacers from 
compact hCRISPRi-v2 library and ligating them into lentiviral plasmid pU6-sgRNA EF1α-puro-
t2a-BFP (Addgene 60955) as previously described (Horlbeck et al., 2016), or using a similar 
vector where the BFP marker was replaced with RFP. Protospacer sequences used for individual 
knockdowns are listed in Table 5. The resulting sgRNA expression vectors were packaged into 
lentivirus by transfecting HEK293T with standard packaging vectors using TransIT-LTI 
Transfection Reagent (Mirus, MIR 2306). The viral supernatant was harvested 2–3 days after 
transfection and filtered through 0.45 μm PVDF filter and/or frozen prior to transduction into 
CRISPRi knockdown cell lines described above. 
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GFP11-GIGYF2 tagged HEK293T cells were generated as previously described 
(Leonetti et al., PNAS, 2016), using targeting sgRNA (AATACGGAACAGAATGGCAG) and 
ssDNA 
oligo(TATTTTTCTCGTTAACAGGTTTCTTCACATATAAAAATCTATTGTAAAAATACG
GAAAAGAatgcgtgaccacatggtccttcatgagtatgtaaatgctgctgggattacaGGCGGTGGAGGGAGTggcgg
aggtGGATCCGCAGCGGAAACGCAGACACTGAACTTTGGGCCTGAATGGTGAGTTTTC
AAAATCTCAT).  
ZNF598 knockout cell line was generated by transfecting K562 CRISPRi cells with an 
all-in-one vector pSpCas9(BB)-2A-GFP (PX458) (Addgene plasmid #48138). This vector was 
modified to express two sgRNAs targeting ZNF598 [ACCGCTGCTCTACCAAGATG], 
[ATGGGGACTTTGCCTCACTG]. Three days post transfection, GFP positive cells were sorted 
into single cells. These clones were expanded and ZNF598 knockout was confirmed by western 
blot for protein expression (Bethyl Laboratories, A305-108A-T), and genotyped with Genewiz 
amplicon-ez sequencing. The CRISPR-Cas9 induced genome edits were identified by using the 
knock-knock computational pipeline developed by Canaj and colleagues. 
4.5. Genome-scale CRISPRi screening 
Genome-scale screens were conducted similar to previously described screens (Gilbert et 
al., 2014; Horlbeck et al., 2016). The CRISPRi compact library (5 sgRNA/TSS) CRISPRi-v2 
(Addgene, Cat#83969) were transduced in duplicate into K562 CRISPRi cells at MOI < 1 
(percentage of transduced cells 2 days after transduction: 20%–40%). Replicates were 
maintained separately in 1.5 L of RPMI-1640 in 3 L spinner flasks for the course of the screen. 2 
days after transduction, the cells were selected with 1 mg/mL puromycin for 2 days, until 
transduced cells accounted for 80%–95% of the population. The cells were maintained in spinner 
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flasks by daily dilution to 0.5 ∙ 106 cells /mL at an average coverage of greater than 500 cells per 
sgRNA for the duration of the screen. Genomic DNA was isolated from frozen cells, and the 
sgRNA-encoded regions were enriched, amplified, and prepared for sequencing as described 
previously (Gilbert et al., 2014). 
FACS based screen  
Cells were sorted using BD FACS Aria2 2 days after recovery from puromycin selection 
based on GFP fluorescence of GFPNon-stop reporter. Cells with the highest (~30%) and lowest 
(~30%) GFP expression were collected and immediately frozen. Approximately 30 million cells 
were collected per group.  
Growth based Screen  
K562 CRISPRi cells were infected with control sgRNA or sgRNA targeting NEMF that 
expressed RFP as a marker. RFP positive cells were sorted on a BD FACSAria2. Both cell lines 
were infected with the hCRISPR-v2 library. 100,000 cells from both cell lines were harvested 
after recovery from puromycin selection as Day 0, and then again after 10 doublings.  
Screen analysis 
Sequencing reads were aligned to the CRISPRi v2 library sequences, counted, and 
quantified using the Python-based ScreenProcessing pipeline 
(https://github.com/mhorlbeck/ScreenProcessing; Horlbeck et al., 2016). Generation of negative 
control genes and calculation of phenotypes and Mann-Whitney p-values was performed as 
described previously (Gilbert et al., 2014; Horlbeck et al., 2016). GFP phenotypes were 
calculated from the top 30% GFP sorted samples, divided by the bottom 30% GFP. Phenotypes 
from sgRNAs targeting the same gene were collapsed into a single GFP stabilization phenotype 
using the average of the top three scoring sgRNAs (by absolute value) and assigned a p-value 
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using the Mann-Whitney test of all sgRNAs targeting the same gene compared to the non-
targeting controls. All additional CRISPRi screen data analyses were performed in Python 2.7 
using a combination of Numpy (v1.12.1), Pandas (v0.17.1), and Scipy (v0.17.0). For all 
experiments, details of quantification and statistical methods used are described in the 
corresponding figure legends or results sections.  
 
4.6. Individual evaluation of sgRNA phenotypes 
Single sgRNA expression vectors were individually cloned by annealing complementary 
synthetic oligonucleotide pairs (Integrated DNA Technologies) for each sgRNA with flanking 
BstXI and BlpI restriction sites and ligating the resulting double-stranded segment into either 
BstXI/BlpI-digested pCRISPRi-v2 (marked with a puromycin resistance cassette and BFP 
similar to Horlbeck et al., 2016) or BstXI/BlpI-digested pU6-sgRNA EF1a-puro-t2a-mCherry 
(marked with a puromycin resistance cassette and RFP).  
Dual sgRNA expression vectors were assembled by a two-step cloning procedure. First, 
sgRNAs to be included were cloned into the corresponding individual sgRNA expression 
vectors. sgRNAs destined for the first position of the dual sgRNA vector were cloned into either 
pMJ002 or pCRISPRia-v2 (Addgene #84832), which both contain a mU6 promoter for sgRNA 
expression, and sgRNAs destined for the second position were cloned into pMJ003, which 
contains a hU6 promoter for sgRNA expression. All vectors contain the same constant region 
and pMJ002 and pMJ003 contain specific primer binding sites flanking the sgRNA expression 
cassette. Complementary oligonucleotides (Integrated DNA Technologies) containing the 
sgRNA sequence and ligation overhangs were annealed and ligated into the corresponding 
BstXI/BlpI-digested sgRNA expression vectors. Single clones from this procedure were used as 
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templates for the second assembly step, in which the sgRNA expression cassettes containing the 
U6 promoter, sgRNA sequence, and constant region were assembled into a vector backbone 
containing a puromycin resistance marker and BFP (pCRISPRia-v2 [Addgene #84832]) or 
mCherry (a version of pU6-sgCXCR4-2 [Addgene #46917] modified to include a BlpI site). The 
desired sgRNA expression cassettes were PCR-amplified (pMJ002-based constructs: oMJ0767 
[GTTAGTACCGGGCCCGC] and oMJ0768 
[CCATAGCTGAGTGTAGATTCGAGCAAAAAAAGCACCGACTCGG]; pCRISPRia-v2-
based constructs: oMJ0873 
[CCAGTTTGGTTAGTACCGGGCCCGCTCTAGAGATCCGACGCGC] and oMJ0768; 
pMJ003-based constructs: oMJ0612 [GCTCGAATCTACACTCAGCTATGG] and oMJ0613 
[GCCGCCTAATGGATCCTAG]) and inserted into XbaI/XhoI-digested backbone by a single 
three-piece Gibson assembly step. 
Protospacer sequences used for individual evaluation are listed in Table 5. The resulting 
sgRNA expression vectors were individually packaged into lentivirus. These sgRNA vectors 
were transduced into K562-dCas9 cells expressing GFPNon-stop at MOI < 1 (20 – 40% infected 
cells). BFP and GFP protein levels were measured by flow cytometry at day 5 post infection. 
Median fluorescent values were calculated for each cell line using FlowJo software and 
compared fluorescent levels after sgRNA knockdown to a cell line expressing to a non-targeting 
sgRNA.  
Internally controlled growth assays: 
Dual sgRNA growth phenotypes were performed by transducing cells with dual sgRNA 
expression constructs at MOI < 1 (15 – 30% infected cells). The fraction of sgRNA-expressing 
cells was measured from 4-16 days after infection by flow cytometry on an LSR-II (BD 
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Biosciences). A population of infected cells was selected to purity with puromycin (1 mg/mL), 
allowed to recover for 1 day, and harvested for measurement of mRNA levels by RT-qPCR (see 
below). Experiments were performed in duplicate from the infection step. The expected double 
phenotype score was calculated by adding the phenotype of both sgRNAs on day 16. Epistasis 
was measured by subtracting the expected phenotype from the measured phenotype of dual 
knockdowns.  
 
4.7. Ribosome profiling and RNA sequencing 
Ribosome Profiling:  
K562-dCas9 cell line stably expressing GFPNon-stop was infected with lenti vectors 
containing a guide RNA against one gene or non-targeting guide RNA (Table 5).  Cells were 
selected using FACS to recover cells containing sgRNA (labeled with RFP). Cyclohexamide was 
added (100mg/ul) to the cells and they were incubated for 5 minutes at 37 °C and then pelleted at 
400g for 5 minutes. Media was removed and cell pellets were immediately snap frozen. Libraries 
were prepared according to McGlincy and Ingolia, Methods, 2017. 
RNA sequencing: 
RNA was extracted using Zymo mini RNA prep (R2053) and libraries were cloned using 
Illumnia true stranded total RNA seq kit (20020596).  
Ribosome profiling and RNAseq analysis: 
Ribosome profiling and RNA-seq libraries were sequenced on an Illumina HiSeq 4000 as 
single end 50-bp reads (UCSF Center for Advanced Technology) at a depth of 22-64 million 
reads per library. Ribosome profiling reads were processed by removing 3’ linker sequences 
using FASTX clipper and de-multiplexed using FASTX barcode splitter 
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(http://hannonlab.cshl.edu/fastx_toolkit/). Sample barcodes and unique molecular identifiers 
were trimmed using a custom Python script. Next, abundant reads were filtered by aligning to a 
custom library of human rRNAs, tRNAs, and primer sequences using bowtie v1.2 (http://bowtie-
bio.sourceforge.net/). All remaining reads were aligned to a modified human genome 
(GRCh38.92 with addition of our CRISPRi construct and the GFPNon-stop) using tophat v2.1.1 
(https://ccb.jhu.edu/software/tophat/; relevant parameters: --read-mismatches=1 and --no-novel-
juncs). After alignment, uniquely mapping reads were extracted, and plastid 
(https://plastid.readthedocs.io) was used to obtain gene-level read counts and normalized counts, 
reads per kilobase per million mapped reads (RPKM). To assign reads to genomic positions, a p-
site offset of 12 nucleotides was determined by calculating the average distance of the start 
codon peak from the start codon (plastid psite). To assess the quality of the ribosome profiling 
data, we confirmed that the aligned reads displayed the expected three nucleotide periodicity 
(phasing) and that the majority of ribosome footprints had a length of 28-31 bp for all libraries. 
We also confirmed that the CRISPRi system produced robust target knockdown on the day of the 
experiment at the level of ribosome footprints (knockdown of target genes >88% for all genes). 
The RNA-seq libraries were processed using the same pipeline as the ribosome profiling 
libraries, with the exception that tophat was run with –read-mismatches=2 due to the longer 
RNAseq read length. All downstream analyses were performed using the Python libraries 
pandas, plastid, matplotlib, seaborn, numpy, and scipy. 
For Figure 12A footprints from K562 CRISPRi cells bearing non-targeting sgRNA are 
plotted as reads per million. Here, we plotted all aligned reads rather than uniquely aligned reads 
to visualize read density in the GFPNon-stop MALAT1 triple helix, which is identical to the 
endogenous MALAT1 lncRNA. To confirm that the reads aligning to the MALAT1 triple helix 
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in the GFPNon-stop are not derived from the endogenous MALAT1 lncRNA, we performed 
ribosome profiling in a K562 CRISPRi cell line without the GFPNon-stop reporter. Here, we found 
that the endogenous MALAT1 background rate was <10% of the GFPNon-stop footprints in the 
MALAT1 triple helix, suggesting that the GFPNon-stop triple helix is indeed translated. For Figure 
19C translational efficiencies were calculated by normalizing the GFPNon-stop GFP ribosome 
footprint rpm to the GFPNon-stop RNAseq rpm.  
 
4.8. RT-qPCR   
Total RNA was isolated from frozen cell samples using TRIzol reagent (Thermo Fisher 
Scientific) and Phase Lock Gel tubes (VWR), treated with Turbo DNase (Thermo Fisher 
Scientific), or using Direct-zol RNA MiniPrep kit. Reverse-transcription was carried using M-
MLV (Thermo Fisher Scientific) or SSIII Reverse-transcriptase (Thermo Fisher Scientific) with 
random hexamer primers (Thermo Fisher Scientific, SO124) in the presence of RNaseIN 
Recombinant Ribonuclease Inhibitor (Thermo Fisher Scientific). Quantitative PCR (qPCR) was 
performed with Kappa Sybr Fast qPCR 2x Mix (Roche), according to the manufacturer's 
instructions on a LightCycler 480 Instrument (Roche). Experiments were performed in technical 
triplicates. RT-qPCR primers used are listed in (Table 6). 
 
4.9. Immunoprecipitation and western blot in mammalian cell culture 
Cells were lysed in buffer containing 10mM Tris 7.5, 150 mM NaCl, 0.5% NP-40, 5 mM 
Mg2Cl, and 1x HaltTM Protease Inhibitor Cocktail (Thermo Fisher Scientific). The lysates were 
cleared by centrifugation at 20,000 x g for 10 min and bound to GFP-Trap Magnetic Beads 
(Chrometech) for 2h at 4 °C. Beads were washed 3 times with IP Buffer (10mM Tris 7.5, 150 
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mM NaCl, 0.1% NP-40, 5 mM Mg2Cl). Bound material was eluted by boiling in Laemmli Buffer 
for 10 min at 90°C.  
Proteins were separated on Bolt® 4-12% Bis-tris gels (Thermo Fisher Scientific), 
transferred to PVDF membrane using the Mini Trans-Blot Cell (Bio-Rad) according to the 
manufacturer’s instructions, blocked with 5% milk in TBS, and subsequently probed. Rabbit anti 
ZNF598 antibody (Bethyl Laboratories, A305-108A-T), rabbit anti GIGYF2 antibody (Bethyl 
Laboratories, A303-731A-M), and rabbit anti 4EHP antibody (Cell Signaling, 6916S) primary 
antibodies were used. LI-COR IRDye800/IRDye700 anti-rabbit (Odyssey) secondary antibody 
was used at 1:10,000 dilution. All blots were visualized using the LI-COR (Odyssey) system.  
 
4.10. ZNF598 Mass Spectrometry 
Cell lines 
3X-FLAG-tagged ZNF598 overexpressing (ZNF598-OE) Flp-In T-Rex 293 cells (kind 
gift from Dr. Nahum Sonenberg and Dr. Thomas Tuschl, Garzia et al., Nature Communications, 
2017) were grown in high-glucose Dulbecco’s Modified Eagle Medium (Thermo Fisher, 
11995040, containing 4 mM L-Glutamine and 1 mM sodium pyruvate) supplemented with 10% 
(v/v) fetal bovine serum. The affinity purification mass spectrometry experiment was performed 
in biological triplicate. Two million low-passage cells were seeded per 10 cm dish. Expression of 
3X-FLAG-tagged ZNF598 was induced (24 hours post seeding) for 24 hours by the addition of 
doxycycline at 1 µg/ml at final concentration.  
FLAG-immunoprecipitation of 3X-FLAG-ZNF598 from HEK293 cells  
Cells were washed with warm PBS (containing 360 µM emetine), and harvested in ice-
cold lysis buffer (50 mM TRIS pH 8.0, 150 mM KCl, 15 mM MgCl2.6H2O, 5% glycerol) 
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supplemented with 1% Triton X-100, 360 µM emetine, 20 mM N-ethylmaleimide, 80 units 
TURBO DNase (Thermo Fisher, AM2238) and protease inhibitors (cOmplete Protease Inhibitor 
Cocktail, Roche; Protease Inhibitor Cocktail, Millipore Sigma; and PMSF, Millipore Sigma). 
Cell lysates were clarified in a tabletop micro-centrifuge (15 minutes, 4°C). Equal protein 
amounts from the clarified supernatant were used for each immunoprecipitation. The clarified 
supernatant was incubated with ANTI-FLAG-Agarose M2 affinity gel (Millipore Sigma 
#A2220, 15 µl of packed affinity resin) for 1 hour, washed four times with 400 µl wash 1 buffer 
(lysis buffer supplemented with 0.1% Triton X-100 and 360 µM emetine), then washed four 
times with wash 2 buffer (50 mM TRIS pH 8.0, 150 mM KCl, 15 mM MgCl2.6H2O 
supplemented with 360 µM emetine), and eluted in 80 µl elution buffer (50 mM TRIS pH 8.0, 
150 mM KCl, 15 mM MgCl2.6H2O supplemented with 400 µg/ml 3X FLAG-peptide (Millipore 
Sigma, #F4799)). Eluates were flash frozen in liquid nitrogen and stored at -80°C prior to protein 
digestion.  
Protein Digestion 
Protein extracts (4 µg) were diluted up to 300 µl in 10 mM triethyl ammonium 
bicarbonate (TEAB) and were reduced with 15 µl of 7.5 mg/ml DL-dithiothreitol (DTT) (60°C, 1 
hour). After cooling to room temperature, samples were alkylated with 15 µl of 18.5 mg/ml 
iodoacetamide for 15 minutes at room temperature in the dark.  Reduced and alkylated proteins 
were buffer-exchanged on a 30 kDa molecular weight spin cartridge (Amicon Ultra 0.5 ml, 
Millipore Sigma) and washed four times with 400 µl 10 mM TEAB.  Proteins were digested 
overnight at 37°C on the filter with 300 µl Trypsin (20 µg in 3 ml 10 mM TEAB, Promega 
Sequencing Grade Modified Trypsin). Additional Trypsin (100 µl of 10 mg/ml) was added the 
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next morning (37°C, 1 hour). Peptides were removed from the top of the filter and the filter was 
washed twice with 300 2% acetonitrile, 0.1% formic acid. All washes were combined and dried.  
Liquid Chromatography and Mass Spectrometry 
Liquid Chromatography and Mass Spectrometry was performed at the Mass 
Spectrometry and Proteomics Core, JHMI. Peptides were analyzed by liquid chromatography 
interfaced with tandem mass spectrometry (LC/MS/MS) using a Waters nanoACQUITY UPLC 
system (www.waters.com) interfaced with an Orbitrap FusionTM LumosTM TribridTM Mass 
Spectrometer (www.thermofisher.com). Fractions were resuspended in 20 µl loading buffer (2% 
acetonitrile in 0.1% formic acid) and analyzed by reverse phase liquid chromatography coupled 
to tandem mass spectrometry.  Peptides (50%, approx. 1 µg) were loaded onto a C18 trap (S-10 
µM, 120 Å, 75 µm x 2 cm, YMC, Japan) and subsequently separated on an in-house packed 
PicoFrit column (75 µm x 200 mm, 15u, +/-1 µm tip, New Objective) with C18 phase (ReproSil-
Pur C18-AQ, 3 µm, 120 Å, www.dr-maisch.com) using 2-90% acetonitrile gradient at 300 
nl/min over 120 min. Eluting peptides were sprayed at 2.0 kV directly into the Lumos. 
Survey scans (full MS) were acquired from 350-1800 m/z with data-dependent 
monitoring with a 3 sec cycle time. Each precursor individually isolated in a 1.6 Da window and 
fragmented using HCD activation collision energy 30 and 15 sec dynamic exclusion, first mass 
being 120 m/z. Precursor and fragment ions were analyzed at resolutions 120,000 and 30,000, 
respectively, with automatic gain control (AGC) target values at 4e5 with 50 ms maximum 
injection time (IT) and 1e5 with 100 ms maximum IT, respectively.   
Processing of Mass Spectrometry Data  
Raw data was processed and analyzed using the MaxQuant software suite (Cox and 
Mann, Nature Biotechnology, 2008). Default settings were used except that ‘Match between 
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runs’ was turned on to transfer peptide identification from an LC-MS run, in which the peptide 
has been identified by MS/MS, to another LC-MS run, in which no MS/MS data for the same 
peptide was acquired or no peptide was assigned (Tyanova et al., Nature Methods, 2016). Search 
parameters were as follows: 
a maximum of two missed cleavages were allowed, cysteine carbamidomethyl was included as a 
fixed modification, and variable modifications included oxidation of methionine, protein N-
terminal acetylation, deamidation of glutamine and asparagine, phosphorylation of serine, 
threonine and tyrosine, and Gly-Gly ubiquitin remnant on lysine. Database search was performed 
with Andromeda (Cox and Mann, Nature Biotechnology, 2008; Cox et al., Journal of Proteomic 
Research, 2011) against Uniprot human database (UP000005640_9606.fasta; downloaded on 
09/10/2018) with common serum contaminants and enzyme sequences. False discovery rate 
(FDR) was set to 1% at both the peptide spectrum match (PSM) and protein level. A minimum 
peptide count required for protein quantification was set to two. Protein groups were further 
analyzed using the Perseus software suite (Tyanova et al., Nature Methods, 2016). Common 
contaminants, reverse proteins and proteins only identified by site were filtered out. LFQ values 
were transformed to log2 space and intensity distributions were checked to ensure that data was 
normally distributed. 
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Table 1. Yeast strains used in this study. 
name  strain  Genotype  source  
BY4741 BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 this study  
pdr5Δ yKK205 BY4741 pdr5Δ::KanMX this study  
ltn1Δ yKK178 BY4741 ltn1Δ::KanMX this study  
rqc2Δ yKK179 BY4741 rqc2Δ::KanMX this study  
RQC2mut/ltn1Δ yKK272 BY4741 rqc2Δ::RQC2mut ltn1Δ::KanMX this study  
rqc2Δ/ltn1Δ yKK287 BY4741 rqc2Δ::KanMX ltn1Δ::URA3 this study  
RQC2mut yKK108 BY4741 rqc2Δ::RQC2mut this study  
ltn1ΔRING yKK102 BY4741 Ltn1ΔRING::NatMX Ref. 11 
pdr5Δ/ltn1Δ yKH16 BY4741 pdr5Δ::Kan ltn1Δ::Nat this study  
pdr5Δ/rqc2Δ yKK226 BY4741 pdr5Δ::Kan rqc2Δ:: Nat this study  
pdr5Δ/RQC2mut yKH21 BY4741 pdr5Δ::Kan rqc2Δ::RQC2mut this study  
pdr5Δ/ltn1Δ/RQC2mut yKH22 BY4741 pdr5Δ::Kan ltn1Δ::Nat rqc2Δ::RQC2mut this study  
ski2Δ yKK327 BY4741 ski2Δ::Ura this study  
ski2Δ/RQC2mut yKK328 BY4741 ski2Δ::Ura rqc2Δ::RQC2mut this study  
ski2Δ/rqc2Δ yKK329 BY4741 ski2Δ::Ura rqc2Δ::Kan this study  
ski2Δ/ltn1Δ yKK330 BY4741 ski2Δ::Ura ltn1Δ::Kan this study  		
Table 2. Yeast plasmids used in this study. 
 
Name  ID Backbone  Expression  Source  
GFP20Lys  pKK148 pRS313 pTDH3-GFP20Lys-3xHA-TEV-R12-RFP this study  
GFPLys-free  pKK135 pRS313 pTDH3-GFPLys-free-3xHA-TEV-R12-RFP this study  
GFP20Lys (37 linker)  pKK168 pRS313 
pTDH3-GFP20Lys-3xHA-TEV(no linkers) -
R12-RFP this study  
GFP19Lys (51 linker)  pKK140 pRS313 
pTDH3-GFP19Lys(K238R)-3xHA-TEV-R12-
RFP this study  
3xFLAG XTEN0 pKK151 pRS313 pTDH3-GFPLys-free-3xFlag-TEV-R12-RFP this study  
3xFLAG XTEN10 pKK190 pRS313 
pTDH3-GFPLys-free-3xFlag-XTEN10-TEV-
R12-RFP this study  
3xFLAG XTEN20 pKK191 pRS313 
pTDH3-GFPLys-free-3xFlag-XTEN20-TEV-
R12-RFP this study  
3xFLAG XTEN40 pKK192 pRS313 
pTDH3-GFPLys-free-3xFlag-XTEN40-TEV-
R12-RFP this study  
3xFLAG XTEN80 pKK198 pRS313 
pTDH3-GFPLys-free-3xFlag-XTEN80-TEV-
R12-RFP this study  
His3Lys-free  pKK172 pRS316 pTDH3-His3Lys-free-3xHA-TEV-R12-RFP this study  
His3Lys-free 3xFLAG  pKK175 pRS316 pTDH3-His3Lys-free-3xFlag-TEV-R12-RFP this study  
His3Lys-free 2xLys pKK174 pRS316 
pTDH3-His3Lys-free-3xHA-2Lys-TEV-R12-
RFP this study  
GFPLys-free 2xLys pKK136 pRS313 
pTDH3-GFPLys-free-3xHA-TEV-2Lys-R12-
RFP this study  
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Name  ID Backbone  Expression  Source  
 
1K XTEN0 pKK218 pRS313 pTDH3-GFPLys-free-3xHA-1K-TEV-R12-RFP this study  
1K XTEN10 pKK219 pRS313 
pTDH3-GFPLys-free-3xHA-1K-XTEN10-
TEV-R12-RFP this study  
1K XTEN20 pKK220 pRS313 
pTDH3-GFPLys-free-3xHA-1K-XTEN20-
TEV-R12-RFP this study  
1K XTEN40 pKK221 pRS313 
pTDH3-GFPLys-free-3xHA-1K-XTEN40-
TEV-R12-RFP this study  
2K XTEN20 pKK242 pRS313 
pTDH3-GFPLys-free-3xHA-2K-XTEN20-
TEV-R12-RFP this study  
2K XTEN25 pKK243 pRS313 
pTDH3-GFPLys-free-3xHA-2K-XTEN25-
TEV-R12-RFP this study  
2K XTEN30 pKK244 pRS313 
pTDH3-GFPLys-free-3xHA-2K-XTEN30-
TEV-R12-RFP this study  
2K XTEN35 pKK245 pRS313 
pTDH3-GFPLys-free-3xHA-2K-XTEN35-
TEV-R12-RFP this study  
NSD GFPLys-free  pKK189 pRS313 
pTDH3-GFPLys-free-
3xHA_TEV_(AAA)x10_Rz  this study  
RQC2 pKK187 pRS426 pPGK-RQC2   this study  
RQC2mut pKK182 pRS426 pPGK-RQC2mut this study  
RQC2-HA pKK183 pRS426 pPGK-RQC2-HA  this study  
RQC2mut-HA  pKK184 pRS426 pPGK-RQC2mut-HA   this study  
Myc-Ub  pUb221   pCUP1-3xHis-Myc-Ub  Finley Lab  
GFP20Lys-3xFLAG pKK150 pRS313 pTDH3-GFP20Lys-3xFLAG-TEV-R12-RFP this study  
unfolded GFP  pKK260 pRS313 
pTDH3-DHFR-GFPLys-free(100AA)-3xHA-
1K-XTEN40-TEV-R12-RFP this study  
 
 
Table 3. Yeast qPCR Primers  
 
Primer Sequence  
GFP F cgtgaacaaccaccacttca 
GFP R gtctgggtgccctcgtag 
ACT1 F tccgtctggattggtggt 
ACT1 R tgagatccacatttgttggaag 
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Table 4: Mammalian plasmids used in this study 
  
Name		 ID	 Backbone		 Expression		 Source		
GFP Non-stop pKK100 pcDNA3 pCMV-BFP-t2a-GFP-Malat1 this study  
GFP Non-stop pKK122 piggybac  pEIF2a-BFP-T2A-GFP-Malat1 this study  
GFP Stop pKK357 pcDNA3 pCMV-BFP-t2a-GFP-STOP-Malat1 this study  
GFP PolyA pKK358 pcDNA3 pCMV-BFP-t2a-GFP-STOP-polyA this study  
K20 pKH21 piggybac pEIF2a-BFP-T2A-GFP-K20-RFP this study  
RFP Non-stop pKH63 piggybac GFP-pA; RFP-MALAT1 this study  
RFP Stop  pKH64 piggybac GFP-pA; RFP-STOP-MALAT1 this study  
yeast control 
reporter     RFP-pA; GFP-T2A-FLAG-His3 
D'Orazio et al., 
eLife 2019 
yeast NGD 
reporter     RFP-pA; GFP-T2A-FLAG-His3(CGA)12 
D'Orazio et al., 
eLife 2019 
GFP MS2-Stop pKK306 pcDNA  
pCMV-3xMS2_BFP-t2a-GFP-stop-stop-
Malat1 this study  
GFP MS2-Stop pKK307 piggybac 
pEIF2a-3xMS2_BFP-IRES-GFP-stop-stop-
Malat1 this study  
MS2BP pKK308 pcDNA  MS2BP-IRES-mCherry this study  
MS2BP-GIGYF2 pKK309 pcDNA  MS2BP-GIGYF2-IRES-mCherry this study  
MS2BP-ZNF598 pKK375 pcDNA3 MS2BP-ZNF598-IRES-mCherry this study  
MS2BP-4EHP pKK318 pcDNA3 MS2BP-4EHP-IRES-mCherry this study  
MS2BP-
ZNF598_C29A pKK391 pcDNA3 MS2BP-ZNF598_C29A-IRES-mCherry this study  
MS2BP-
ZNF598_deltaRI
NG pKK392 pcDNA3 MS2BP-ZNF598_deltaRING-IRES-mCherry this study  
MS2BP pKK478 piggybac  MS2BP-IRES-Mcherry this study  
MS2BP-
ZNF598_deltaRI
NG pKK479 piggybac  MS2BP-ZNF598deltaRING-IRES-mCherry this study  
MS2BP-GIGYF2 pKK480 piggybac  MS2BP-GIGYF2-IRES-mCherry this study  
MS2BP-4EHP pKK481 piggybac  MS2BP-4EHP-IRES-mCherry this study  
MS2BP-ZNF598 pKK482 piggybac  MS2BP-ZNF598WT-IRES-mCherry this study  
	
	
Table 5: Protospacers used in this study	
   
Target  sequence 
non-targeting 001 GAACGACTAGTTAGGCGTGTAG 
NEMF GAGTACGGCGCGGAGGTCAA 
GIGYF2 GGCAGGGGAGCGACACGGAA 
4EHP GCCTGAGGCAGTGGCGACAG 
ZNF598 GGCCGGATCCCGGACCATGG 
non-targeting 002 GTGTGCAACCTCCGCCGTTGG 
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Table 6: Mammalian RT-qPCR primers used in this study 
   
			
Target  forward primer  reverse primer  
ZNF598 aaaggtgtacgcattgtacagg ctccaggtccccgaagag 
4EHP  gacaggccacagtgacttcc gcagccgaataatccacttg 
GIGYF2 tctgtgggtcaggaatttgg gacatctgaccacaaccaaaga 
Actin gctacgagctgcctgacg ggctggaagagtgcctca 
GFP_1 tgaccacatggtccttcttg atagttcatccatgccatgtgta 
GAPDH acgggaagcttgtcatcaat catcgccccacttgatttt 
RFP cccgtaatgcagaagaagacc gcttgatctcgcccttca 
GFP_2 gtggatggcgctcttgaa cgacggcggctactacag 
NEMF ctatatgaaaacaacatccaacttcag cgtcagtatgtcttcaactggttt 
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